OSSFF (Embla Medical hf) OCF Margin %: 3.98% (As of Mar. 2026) — 70% Below Median


OSSFF Embla Medical hf OSSFF
92 GF Score
Price $4.15
GF Value $5.49
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf OCF Margin %?

Embla Medical hf OSSFF 92 OCF Margin % is 3.98% as of Mar. 2026, which is 70% below its 10-year median of 13.29. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Embla Medical hf ranks better than 65.15% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Embla Medical hf's Cash Flow from Operations for the three months ended in Mar. 2026 was $9.3 Mil. Embla Medical hf's Revenue for the three months ended in Mar. 2026 was $232.4 Mil. Therefore, Embla Medical hf's OCF Margin % for the quarter that ended in Mar. 2026 was 3.98%.

As of today, Embla Medical hf's current OCF Yield % is 7.41%.

The historical rank and industry rank for Embla Medical hf's OCF Margin % or its related term are showing as below:

OSSFF' s OCF Margin % Range Over the Past 10 Years
Min: 8.46   Med: 13.29   Max: 14.65
Current: 13.36


During the past 13 years, the highest OCF Margin % of Embla Medical hf was 14.65%. The lowest was 8.46%. And the median was 13.29%.

OSSFF's OCF Margin % is ranked better than
65.15% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs OSSFF: 13.36


Embla Medical hf OCF Margin % Related Terms


Embla Medical hf OCF Margin % Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf OCF Margin % Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.99 8.46 12.01 13.58 14.28

Embla Medical hf Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.81 9.55 19.52 19.63 3.98

OSSFF vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Embla Medical hf's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's OCF Margin % falls into.


OSSFF
92GF Score
Embla Medical hf OSSFF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Embla Medical hf's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=132.618/928.689
=14.28 %

Embla Medical hf's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=9.254/232.395
=3.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 3.98% mean?
Embla Medical hf (OSSFF) has a OCF Margin % of 3.98% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Embla Medical hf and its competitors. This is 70% below median its historical median of 13.29. Over the past decade, Embla Medical hf's OCF Margin % has ranged from 8.46 to 14.65. According to the industry distribution chart, Embla Medical hf ranks #284 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is Embla Medical hf's OCF Margin % too high?
Embla Medical hf's current OCF Margin % of 3.98% is 70% below median its 10-year median of 13.29. Over the past 10 years, this metric has ranged from a low of 8.46 to a high of 14.65. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Embla Medical hf's value of 3.98% is 32.1% below this industry median. Based on the distribution chart, Embla Medical hf ranks #284 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #284 out of 815 companies for OCF Margin %. This puts Embla Medical hf in the upper half of its industry. The industry median OCF Margin % is 5.86. Embla Medical hf's value of 3.98% is 32.1% below this benchmark. Historically, Embla Medical hf's own OCF Margin % has ranged from 8.46 to 14.65 over the past decade. While the company's 10-year median is 13.29 vs. the industry median of 5.86, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current OCF Margin % of 3.98% is 32.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current OCF Margin % is 3.98%, which is 70% below median its own 10-year median of 13.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current OCF Margin % of 3.98%. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current OCF Margin % is 3.98%, which is 70% below median its 10-year median of 13.29 and 32.1% below the Medical Devices & Instruments industry median of 5.86. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current OCF Margin % is 3.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.

Key valuation signals for OSSFF:

  • OCF Margin %: 3.98% (70% below median its 10-year median of 13.29)
  • GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
  • GF Score™: 92/100 with 2 warning signs
  • Industry Position: 32.1% below the Medical Devices & Instruments median (#284 of 815)

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score

Get the complete analysis for OSSFF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$5.49
GF Value